Author Correction: Combination of KIR2DS4 and FcγRIIa polymorphisms predicts the response to cetuximab in KRAS mutant metastatic colorectal cancer.
Sci Rep
; 9(1): 7706, 2019 May 17.
Article
in En
| MEDLINE
| ID: mdl-31097738
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Prognostic_studies
/
Risk_factors_studies
Language:
En
Journal:
Sci Rep
Year:
2019
Type:
Article
Affiliation country:
Spain